Alkermes Plc (ALKS)
34.84
-0.21
(-0.60%)
USD |
NASDAQ |
Apr 02, 16:00
34.82
-0.02
(-0.06%)
After-Hours: 20:00
Alkermes EPS Diluted (Quarterly) : 0.291 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.699 |
| Avadel Pharmaceuticals Plc | 0.0002 |
| Assertio Holdings, Inc. | -1.858 |
| Amarin Corp. Plc | -0.0587 |
| Amicus Therapeutics, Inc. | 0.0054 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 49.34M |
| Revenue (Quarterly) | 384.55M |
| Total Expenses (Quarterly) | 335.21M |
| Enterprise Value | 4.557B |
| Gross Profit Margin (Quarterly) | 87.65% |
| Profit Margin (Quarterly) | 12.83% |
| Earnings Yield | 4.11% |
| Operating Earnings Yield | 4.32% |
| Normalized Earnings Yield | 4.112 |